Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics Use For Further Treatment Improvement in childreN

NCT03654508 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03654508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics Use For Further Treatment Improvement in childreN
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2018
Completion date
October 18, 2023
Enrollment
102 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children